Prior Stephen David
SEC CIK 2042268 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Chief Strategy Off | 59.1K | — | $10.1K | 5 | 2024-11-04 | 2026-01-05 |
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-07 | 2026-01-05+ | ANTX | AN2 Therapeutics, Inc. | Prior Stephen David | Chief Strategy Off | S - Sale | $1.00 | -6,462 | 59.1K | -10% | -$6,491 |
| 2025-11-06 | 2025-11-04 | ANTX | AN2 Therapeutics, Inc. | Prior Stephen David | Chief Strategy Off | S - Sale | $1.14 | -765 | 65.5K | -1% | -$872.10 | |
| D | 2025-02-28 | 2025-02-26 | ANTX | AN2 Therapeutics, Inc. | Prior Stephen David | Chief Strategy Off | A - Grant | $0.00 | +28.0K | 61.3K | +84% | $0 |
| 2025-01-07 | 2025-01-03 | ANTX | AN2 Therapeutics, Inc. | Prior Stephen David | Chief Strategy Off | S - Sale | $1.34 | -2,029 | 33.3K | -6% | -$2,719 | |
| D | 2024-11-05 | 2024-11-04 | ANTX | AN2 Therapeutics, Inc. | Prior Stephen David | Chief Strategy Off | A - Grant | $0.00 | +10.1K | 35.3K | +40% | $0 |
Purchase Sale Sale after option exercise All abbreviations